AJP - Cell Physiology, Vol 265, Issue 4 C939-C945, Copyright © 1993 by American Physiological Society

ARTICLES

AVP-induced activation of MAP kinase in vascular smooth muscle cells is mediated through protein kinase C

A. Kribben, E. D. Wieder, X. Li, V. van Putten, Y. Granot, R. W. Schrier and R. A. Nemenoff
Department of Medicine, University of Colorado School of Medicine, Denver 80262.

Arginine vasopressin (AVP) has been shown to stimulate tyrosine phosphorylation and activation of p42 mitogen-activated protein (MAP) kinase (p42MAPK) in vascular smooth muscle cells (VSMC). In VSMC, AVP increases free intracellular Ca2+ concentration ([Ca2+]i) and activates protein kinase C (PKC) through activation of phospholipase C. The contribution of PKC and [Ca2+]i in p42MAPK regulation was therefore determined. Activation of PKC by phorbol 12-myristate 13-acetate (PMA) stimulated tyrosine phosphorylation and activation of p42MAPK to the same extent as AVP. Inhibition of PKC by staurosporine or downregulation of PKC by PMA pretreatment abolished AVP-induced stimulation of p42MAPK. When [Ca2+]i was elevated to the same level as with AVP, using either ionomycin (0.1 microM) or thapsigargin (0.1 microM), MAP kinase was only partially activated. Elevation of [Ca2+]i to supraphysiological levels by 1 microM ionomycin stimulated MAP kinase activity to the same extent as AVP. This effect was blocked by downregulation of PKC. The intracellular Ca2+ chelator BAPTA [1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid] blocked AVP-induced [Ca2+]i increase but did not affect AVP stimulation of p42MAPK. Thus AVP-induced activation of p42MAPK requires only the activation of PKC but not an increase in [Ca2+]i.

This article has been cited by other articles:

				S. L. House, S. J. Melhorn, G. Newman, T. Doetschman, and J. E. J. Schultz The protein kinase C pathway mediates cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2 Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H354 - H365. [Abstract] [Full Text] [PDF]

				I. M. Bird, L. Zhang, and R. R. Magness Possible mechanisms underlying pregnancy-induced changes in uterine artery endothelial function Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2003; 284(2): R245 - R258. [Abstract] [Full Text] [PDF]

				D. Xiao and L. Zhang ERK MAP kinases regulate smooth muscle contraction in ovine uterine artery: effect of pregnancy Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H292 - H300. [Abstract] [Full Text] [PDF]

				G. G. Choudhury, C. Karamitsos, J. Hernandez, A. Gentilini, J. Bardgette, and H. E. Abboud PI-3-kinase and MAPK regulate mesangial cell proliferation and migration in response to PDGF Am J Physiol Renal Physiol, December 1, 1997; 273(6): F931 - F938. [Abstract] [Full Text] [PDF]

				C.-P. Sung, A. J. Arleth, C. Eichman, A. Truneh, and E. H. Ohlstein Carvedilol, a Multiple-Action Neurohumoral Antagonist, Inhibits Mitogen-Activated Protein Kinase and Cell Cycle Progression in Vascular Smooth Muscle Cells J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 910 - 917. [Abstract] [Full Text]

				K. Yasunari, M. Kohno, T. Hasuma, T. Horio, H. Kano, K. Yokokawa, M. Minami, and J. Yoshikawa Dopamine as a Novel Antimigration and Antiproliferative Factor of Vascular Smooth Muscle Cells Through Dopamine D1-Like Receptors Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 3164 - 3173. [Abstract] [Full Text]

				R. Higashita, L. Li, V. Van Putten, Y. Yamamura, F. Zarinetchi, L. Heasley, and R. A. Nemenoff Galpha 16 Mimics Vasoconstrictor Action to Induce Smooth Muscle alpha -Actin in Vascular Smooth Muscle Cells through a Jun-NH2-terminal Kinase-dependent Pathway J. Biol. Chem., October 10, 1997; 272(41): 25845 - 25850. [Abstract] [Full Text] [PDF]